NEWS Anthropic IPO prospectus shows key executives and board ↧ · 4m ago →NEWS China has expanded overseas travel restrictions for top AI professionals in private firms to include the families of key personnel. This further tightens measures designed to prevent the outflow of critical know-how and information to the US. Bloomberg's Minmi · 4m ago →NEWS Prosecutors in upstate New York are defending their decision not to bring charges in 2024 after an alleged "gang rape" at a Cornell University fraternity. ABC News' "Nightline" has more. ▻ · 9m ago →NEWS Iran's Revolutionary Guards Spokesperson: Trump is 'a big liar’, US people need to be told the truth. · 10m ago →NEWS US states challenge FAA environmental review of commercial drone package rules ↧ · 13m ago →NEWS FIFA accused UEFA of waging a ‘misinformation campaign’ and trying to influence the race for its presidency as world soccer's governing body urged a US court to reject a discovery request linked to a controversial investment proposal · 14m ago →NEWS An Israeli airstrike killed Izz al-Din Al-Beik, the head of Hamas armed wing in the northern Gaza Strip, Israeli and Palestinian sources said · 18m ago →$XRP XRP Price Prediction: Shorts Pile Up, Setting Up a Potential Squeeze · 19m ago →NEWS BITCOIN HITS $84,000 · 21m ago →NEWS Saifedean Ammous says many token launches follow the same pattern: hype, a price spike, then a drop back to launch levels. He argues rising supply and insider selling often come before a collapse as new buyers run out. · 22m ago →NEWS James Van Straten expects underwriters Morgan Stanley and Goldman Sachs to soon initiate coverage on the stock with buy ratings. The focus now is on what specific factors the banks cite to justify those recommendations. · 22m ago →$MACRO SPANISH RETAIL SALES SA YOY ACTUAL -0.4% (FORECAST -, PREVIOUS -0.3%) $MACRO · 23m ago →NEWS Anthropic IPO prospectus shows key executives and board ↧ · 4m ago →NEWS China has expanded overseas travel restrictions for top AI professionals in private firms to include the families of key personnel. This further tightens measures designed to prevent the outflow of critical know-how and information to the US. Bloomberg's Minmi · 4m ago →NEWS Prosecutors in upstate New York are defending their decision not to bring charges in 2024 after an alleged "gang rape" at a Cornell University fraternity. ABC News' "Nightline" has more. ▻ · 9m ago →NEWS Iran's Revolutionary Guards Spokesperson: Trump is 'a big liar’, US people need to be told the truth. · 10m ago →NEWS US states challenge FAA environmental review of commercial drone package rules ↧ · 13m ago →NEWS FIFA accused UEFA of waging a ‘misinformation campaign’ and trying to influence the race for its presidency as world soccer's governing body urged a US court to reject a discovery request linked to a controversial investment proposal · 14m ago →NEWS An Israeli airstrike killed Izz al-Din Al-Beik, the head of Hamas armed wing in the northern Gaza Strip, Israeli and Palestinian sources said · 18m ago →$XRP XRP Price Prediction: Shorts Pile Up, Setting Up a Potential Squeeze · 19m ago →NEWS BITCOIN HITS $84,000 · 21m ago →NEWS Saifedean Ammous says many token launches follow the same pattern: hype, a price spike, then a drop back to launch levels. He argues rising supply and insider selling often come before a collapse as new buyers run out. · 22m ago →NEWS James Van Straten expects underwriters Morgan Stanley and Goldman Sachs to soon initiate coverage on the stock with buy ratings. The focus now is on what specific factors the banks cite to justify those recommendations. · 22m ago →$MACRO SPANISH RETAIL SALES SA YOY ACTUAL -0.4% (FORECAST -, PREVIOUS -0.3%) $MACRO · 23m ago →

published news · BWB Crime

Novo Nordisk to license experimental GLP-1 pill from China's Hengrui ↧

Published September 29, 2026 at 1:46 AM CDT · Timestamp preserved from the BWB source feed

Share this reportAffiliate links personalize automatically.

X Facebook LinkedIn Reddit WhatsApp Telegram Email

Novo Nordisk to license experimental GLP-1 pill from China's Hengrui ↧ — Original image preserved with the BWB Crime source post

Novo Nordisk to license experimental GLP-1 pill from China's Hengrui ↧ ↧ Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Novo Nordisk will pay $300 million upfront to Jiangsu Hengrui Pharmaceuticals for the rights to an experimental ‌GLP-1 pill, the Chinese drugmaker said on Tuesday.

Open the original public source →

Latest documented BWB result

See Billy's timestamped results and follow-through.

Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.

Review the documented result → Join Discord for Billy's buy and sell alerts →

Historical results are not a promise of future performance. Trading involves substantial risk.

Continue exploring

Related BWB updates

news · Sep 29, 2:20 AM CDTAnthropic IPO prospectus shows key executives and board ↧news · Sep 29, 2:20 AM CDTChina has expanded overseas travel restrictions for top AI professionals in private firms to include the families of key personnel. This further tightens measures designed to prevent the outflow of critical know-how and information to the US. Bloomberg's Minmi news · Sep 29, 2:15 AM CDTProsecutors in upstate New York are defending their decision not to bring charges in 2024 after an alleged "gang rape" at a Cornell University fraternity. ABC News' "Nightline" has more. ▻news · Sep 29, 2:14 AM CDTIran's Revolutionary Guards Spokesperson: Trump is 'a big liar’, US people need to be told the truth.

This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.

Join Discord for Billy's personal buy and sell alerts →

Share this reportAffiliate links personalize automatically.

X Facebook LinkedIn Reddit WhatsApp Telegram Email